TIDMMCC
RNS Number : 3180R
Monchhichi plc
20 September 2017
For Immediate Release 20 September 2017
Monchhichi plc
("Monchhichi" or "the Company")
Audited Results for the year ended 31 March 2017
Re-alignment of Board Responsibilities and future organisational
requirements
Advanced discussions on disposal of Legacy Investments
Monchhichi announces its audited results for the year ended 31
March 2017, together with re-alignment of Board responsibilities in
preparation for recruitment of additional executive and
non-executive members of the team after completion of the proposed
initial investment previously announced.
The accounts for the year ended 31 March 2017 will be posted to
shareholders shortly and will be available on the Company's website
at http://www.monchhichi.life/ later today.
Market Abuse Regulation
The information contained within this announcement is deemed to
constitute inside information as stipulated under the Market Abuse
Regulations (EU) No. 596/2014. Upon the publication of this
announcement, this inside information is now considered to be in
the public domain.
Enquiries:
Buchanan (Financial communications) Tel: +44 (0)20 7466
Richard Oldworth / Henry Harrison-Topham 5000
/ Catriona Flint www.buchanan.uk.com
monchhichi@buchanan.uk.com
Panmure Gordon (Nominated Tel: +44 (0)20 7886
Adviser and Broker) 2500
Dominic Morley / Alina Vaskina
Chairman's Statement
On 23 December 2016 the previous Directors stepped down from the
Board and my fellow Directors and I were appointed. In the
Strategic Report, we describe the bespoke Investment Policy that
was adopted shortly following our appointment. The Directors are
confident that based on their collective experience, knowledge,
capabilities and determination a select number of complementary
conviction investments can be made. We believe that over time this
will lead to a complete transformation of both the Company's and
our shareholders' fortunes.
The Past: Tragic Galore!
I would like to point out that prior to our appointment as
Directors, we were actively assessing two interesting and
significant investment opportunities that required for us to be
fully "battle-ready" during the first calendar half of 2017. This
meant that Monchhichi should have had (i) a clean quoted Company
(ii) a cohesive Board (iii) the appropriate capital framework and
structure (iv) experienced international / sector advisors plus (v)
no unwarranted speculation, rumours and or other potential
distractions.
Despite early encouraging signals, it turned out that, after
multiple diversions, we had spent an amount of both time and money
which rendered a complete clean-out as the only way forward to
secure the correct position for our shareholders. Looking back, we
took the right decision and in an expedited fashion, the situation
has now been cleaned up. In stark contrast, to the costs and
write-offs of the past, the new Directors and initial cornerstone
investor have to date already invested more than GBP3 million in
the Company.
The Start: Solid Foundation
By Q1 2017, being the Company's fourth financial quarter, we had
cleaned up the position and ensured that through a range of
pro-active sequential actions Monchhichi could at last start to
present itself as a credible investee partner.
We have now announced our intention to move from our current AIM
listing to the Official List (by way of Standard Listing under
Chapter 14 of the Listing Rules) and to trading on the London Stock
Exchange's main market for listed securities. This is a pre-emptive
move to accommodate future conviction acquisitions as well as to
enable major international institutional investors to participate
in our development from an early stage.
As part of this process we are seeking shareholder approval for
an extension of our Investment Policy to include the ability to
acquire majority interests in investee companies and make
investments in quoted companies.
Moreover, it is our expectation that during the coming year
further complementary Board appointments shall be made, our reach
into the main international institutional market will expand with
the start of research coverage and we plan to introduce a
pro-active and comprehensive investor communication program from
our financial Q4 onwards.
Organisation Set-up and Requirements
There is a clear and concise plan to transform Monchhichi into a
mainstream alternative player in the technology, media and internet
space globally. With the impending closing of the first transaction
and concurrent move to the Standard List of the Main Market the
Board shall now pursue the recruitment of a full time executive
team. Their drive, determination and all out commitment combined
with relevant experience shall be essential to ensure that we can
deliver the right results for all our stakeholders in the future.
As a first step in this transition, Jean Pascal Tranie has now
returned to his previous role as Non-Executive Director (NED) such
that he can positively challenge the future investment and
acquisition plans. I now return to the role of Executive Chairman
and expect to retain that position until such time that a full time
Chief Executive Officer becomes fully operational.
In the near-term Felipe Wallace Simonsen will continue to be
Finance Director although it is the Board's collective view that
with the rapidly growing importance of this role including acting
as the interface with the investment community a full-time Finance
Director should ideally be based out of Europe.
Finally, it is the intention that two further highly qualified
and internationally experienced NEDs are appointed during the next
twelve months. The Company has recently formed an Audit Committee
as well as a Remuneration Committee and the Board shall on a
regular basis review that its composition, remit and prevailing
corporate governance and other procedures adhere to the highest
standards.
Conviction Investments
As mentioned in previous statements, Monchhichi's plan is to
make a series of cohesive and meaningful Conviction Investments
("CI") and acquisitions that display a clear existing industry
validation and growth trajectory in the Technology, Media and
Internet sectors.
We are at the final stage of completing the first of such
Conviction Investments and look forward to informing our
shareholders in the very near term about the details of this
exciting investment.
The Future
Investments are about quality rather than quantity. Being
totally decisive when your experience, curiosity, gut and deep dive
assessment tells you it's right even when others might not agree,
not get it or not be prepared to take the plunge. We shall always
endeavour to ensure we obtain the right "cornerstone position" and
thereafter with complete conviction and relentless focus
pro-actively help the talent we invest in to be able to
successfully execute their plans par excellence.
Will we find at the right time and invest in the next generation
Apple, Netflix, Facebook, Amazon or Tencent? You bet we shall give
it our best shot. The world requires more inclusive
entrepreneurship through authentic and new collaboration
initiatives. The likely result will be outstanding social and human
centric innovations that future generations simply shall not wish
to live without.
We now have a solid foundation....created in an incredibly short
period of time and we are confident that once CI One is completed
it shall prove an outstanding long-term winner and that likewise
complementary investment opportunities will become available to
Monchhichi. When these can be secured we shall act decisively and
with vigour. The move to trading on the Standard List of the Main
Market should assist us over time in increasing our international
institutional shareholder reach and base and thus materially
improve liquidity in the shares. This will go hand-in-hand with the
appointment of additional members of the team, in both executive
and non-executive capacities. We are therefore excited and
confident about what the future will bring for all our existing and
future stakeholders.
S Fry
Executive Chairman
19 September 2017
The Directors' present their Strategic Report and consolidated
financial statements for the year ended 31 March 2017.
Review of the Business
The Company is in advanced discussions to dispose of the entire
equity interest of Viet Energy Ltd and MOWISAT Mexico SAPI for a
total cash consideration of GBP600,000. As a result of these
ongoing discussions (and no other parties being interested in the
acquisition of these investments) the Directors have concluded that
the carrying value should be impaired by GBP300,000. The Directors
consider that it is not possible to specifically allocate the
GBP300,000 impairment against either of the two investments.
Validation
Prior to making an investment, it is essential to have a clear
understanding of the rapidly and ever evolving dynamics of the TMI
sector. The collective experience, extensive global network and
industry access of the Directors provide us with a broad ranging
perspective and allows us to be selective when it comes to
reviewing meaningful investment opportunities. We expect to focus
on those investment options which in our view have already obtained
demonstrable validation within their sector, with credible and
proven management teams and clear medium term visibility of
accomplishing inflection catalysts that could propel them into
becoming a future category leader.
Conviction
The TMI sector is presently dominated by a handful of global
titans and a select number of well-known vertical niche market
leaders. Achieving success requires relentless focus, determination
and a real proprietary
edge. We expect that, when we decide to make an investment, we
will wish to do so by taking "cornerstone" but non-controlling
positions, typically in the range of 10%-30%, of the capital of the
investee businesses. We therefore wish from the outset to create
the right capital framework such that, over time, your Company will
be properly funded and can use a combination of cash and equity as
the means to make these cornerstone investments.
Proactive Assistance and Endurance
Talented entrepreneurial teams require support behind the
scenes. We wish to engage with the management and their employees,
positively challenge them, pro-actively assist them, and provide
them with creative solutions and options that otherwise might not
be available to them.
Longevity
We intend to let our investments develop, and not have any
particular exit horizon. Our philosophy will be based on
progressive capital growth delivered through a select number of
complementary investments that, over time, can benefit all
stakeholders. The proposed investing policy is set out below.
"To acquire a diverse portfolio of direct and indirect interests
in the technology, media and internet sectors. Investments may be
made in shares, or by the acquisition of assets (including the
intellectual property) of a relevant business, or by entering into
partnerships or joint venture arrangements, or in units in open
ended investment companies, exchange traded funds, commodities and
futures contracts. Such investments may result in the Company
acquiring the whole or part of a company or project (which in the
case of an investment in a company may be private or listed on a
stock exchange, and which may be pre-revenue). Investments may also
be in any type of financial instrument that the Board deems to be
beneficial to increasing shareholder value.
The Company may be an active or a passive investor depending on
the nature of the individual investments. Although the Company
intends to be a medium to long-term investor, there is no minimum
or maximum limit on the length of time that any investment may be
held and short term investments may be made. There will be no limit
on the number of projects which the Company may invest in, and the
Company's financial resources may be invested in a number of
propositions or in just one investment, which may be deemed to be a
reverse takeover. The Company will carry out an appropriate due
diligence exercise on all potential investments and, where
appropriate or required, with the assistance of professional
advisers. While the directors intend to take into account funds
available for investment when assessing the amount of any
investment and the spread of investments, it is not proposed that
there be any maximum investment limit. The Company will require
additional funding as investments are made and new opportunities
arise. The directors may offer new Ordinary Shares by way of
consideration, as well as cash, thereby helping to preserve the
Company's cash resources for working capital. The directors do not
intend to acquire any cross-holdings in other corporate entities
that have an interest in the Ordinary Shares of the Company.
Investments will be long only. The Company may, in appropriate
circumstances, issue debt securities or otherwise borrow money to
complete an investment. The Board's principal focus will be on
achieving capital growth for shareholders.
We wish to develop a portfolio of meaningful investment
positions in exciting TMI companies. It is our intention that the
proposed new investing policy will allow you as existing
shareholders, together with any future shareholders, to become part
of a positively challenging and hopefully rewarding journey.
Our collective focus is on the long term successful and
progressive development of the Company. We wish to ensure that,
from the outset, you as an existing shareholder in the Company
understand that we will endeavour to enable you to proactively
participate in the Company's future success. Your Board is excited
and enthused by the opportunities facing the proposed new team and
we are confident that our collective network will not only provide
some excellent investment opportunities but will also provide a
real differentiator in working closely with the management and
employees of our future investee companies."
Proposed extension to core Investment Policy
As part of the proposed move to the main market of the London
Stock Exchange we shall concurrently request for shareholders to
approve for us to be able to obtain majority equity holdings and
investments in quoted companies.
Consolidated Statement of Comprehensive Income
For the year ended 31 March 2017
Group Note 2017 2016
-------------------------------- ----- ------------ ----------
Continuing Operations GBP GBP
Expenses
General and administrative
expenses 514,997 314,229
Exceptional items 5 1,495,719 268,632
-------------------------------- ----- ------------ ----------
Group Loss from Operations (2,010,716) (582,861)
Other items
Investment revenue 923 -
-------------------------------- ----- ------------ ----------
Loss for the year before
Taxation 4 (2,009,793) (582,861)
Taxation 7 - -
-------------------------------- ----- ------------ ----------
Loss for the year attributable
to equity holders of the
Company (2,009,793) (582,861)
-------------------------------- ----- ------------ ----------
Other comprehensive income - -
Total comprehensive loss
for the year (2,009,793) (582,861)
-------------------------------- ----- ------------ ----------
Loss per Ordinary share
Basic - continuing and
total operations 13 (6.6p) (3.6p)
Diluted - continuing and
total operations 13 (6.6p) (3.6p)
-------------------------------- ----- ------------ ----------
Headline loss per Ordinary
share
Basic - pre exceptional
items 13 (1.7p) (1.9p)
Diluted - pre exceptional
items 13 (1.7p) (1.9p)
================================ ===== ============ ==========
Company
Loss for the year attributable
to equity holders of the
Company (2,017,631) (582,220)
-------------------------------- ----- ------------ ----------
Other comprehensive income - -
Total comprehensive loss
for the year (2,017,631) (582,220)
-------------------------------- ----- ------------ ----------
Consolidated Statement of Financial Position
As at 31 March 2017
Note 2017 2016
------------------------------------- --------- ---------- ------------
GBP GBP
Non-current assets
Available for sale financial assets 8 600,000 300,000
------------------------------------- --------- ---------- ------------
Total non-current assets 600,000 300,000
------------------------------------- --------- ---------- ------------
Current assets
Cash and cash equivalents 1,237,716 592,698
Trade and other receivables 9 49,339 432,109
Total current assets 1,287,055 1,024,807
------------------------------------- --------- ---------- ------------
TOTAL ASSETS 1,887,055 1,324,807
------------------------------------- --------- ---------- ------------
LIABILITIES AND EQUITY
Current liabilities
Trade and other payables 10 138,208 266,110
------------------------------------- --------- ---------- ------------
Total current liabilities 138,208 266,110
------------------------------------- --------- ---------- ------------
Equity
Share capital 12 42,452 568,128
Share premium - 4,265,248
Accumulated surplus/(deficit) 1,706,395 (3,774,679)
------------------------------------- --------- ---------- ------------
Total equity 1,748,847 1,058,697
------------------------------------- --------- ---------- ------------
TOTAL EQUITY AND LIABILITIES 1,887,055 1,324,807
------------------------------------- ---------
Company Statement of Financial Position
As at 31 March 2017
Note 2017 2016
-------------------------------------- ----- ---------- ------------
GBP GBP
Non-current assets
Investment in subsidiary undertaking 8 - -
Available for sale financial assets 600,000 300,000
-------------------------------------- ----- ---------- ------------
Total non-current assets 600,000 300,000
-------------------------------------- ----- ---------- ------------
Current assets
Cash and cash equivalents 1,237,716 578,702
Trade and other receivables 9 49,339 453,943
Total current assets 1,287,055 1,032,645
-------------------------------------- ----- ---------- ------------
TOTAL ASSETS 1,887,055 1,332,645
-------------------------------------- ----- ---------- ------------
LIABILITIES AND EQUITY
Current liabilities
Trade and other payables 10 138,208 266,110
-------------------------------------- ----- ---------- ------------
Total current liabilities 138,208 266,110
-------------------------------------- ----- ---------- ------------
Equity
Share capital 12 42,452 568,128
Share premium - 4,265,248
Accumulated surplus/(deficit) 1,706,395 (3,766,841)
-------------------------------------- ----- ---------- ------------
Total equity 1,748,847 1,066,535
-------------------------------------- ----- ---------- ------------
TOTAL EQUITY AND LIABILITIES 1,887,055 1,332,645
-------------------------------------- -----
As permitted by section 408 of the Companies Act 2006, the
profit or loss element of the Parent Company Statement of
Comprehensive Income is not presented as part of these financial
statements. The Group loss for the financial period of GBP2,009,793
(2016 - GBP582,861) includes a loss of GBP2,017,631 (2016 -
GBP582,220), which was dealt with in the financial statements of
the Company.
Consolidated Statement of Cash Flows
For the year ended 31 March 2017
2017 2016
---------------------------------------------------------- ------------ ----------
GBP GBP
Cash flow from operating activities
Loss for the period before tax (2,009,793) (582,861)
Adjustments for:
Impairment of available for sale financial assets 300,000 268,632
Shares issued for services rendered 530,000 -
Shares issued as settlement of debt - 213,066
Decrease in trade and other receivables 382,770 67,791
(Decrease)/increase in trade and other payables (127,902) 16,620
---------------------------------------------------------- ------------ ----------
Cash used in operations (924,925) (16,752)
---------------------------------------------------------- ------------ ----------
Cash flow from investing activities
Purchase of available for sale financial assets (600,000) -
Proceeds on issue of share capital 2,247,731 -
Share issue costs (77,788) -
Net cash generated from investing activities 1,569,943 -
---------------------------------------------------------- ------------ ----------
Increase/(decrease) in cash and cash equivalents 645,018 (16,752)
Cash and cash equivalents at the beginning of the period 592,698 609,450
---------------------------------------------------------- ------------ ----------
Cash and cash equivalents at the end of the period 1,237,716 592,698
---------------------------------------------------------- ------------ ----------
Company Statement of Cash Flows
For the year ended 31 March 2017
2017 2016
---------------------------------------------------------- ------------ ----------
GBP GBP
Cash flow from operating activities
Loss for the period before tax (2,017,631) (582,220)
Adjustments for:
Impairment of investments 300,000 268,632
Shares issued for services rendered 530,000 -
Shares issued as settlement of debt - 213,066
Decrease in trade and other receivables 404,604 56,034
(Decrease)/increase in trade and other payables (127,902) 16,620
---------------------------------------------------------- ------------ ----------
Cash used in operations (910,929) (27,868)
---------------------------------------------------------- ------------ ----------
Cash flow from investing activities
Purchase of available for sale financial assets (600,000) -
Proceeds on issue of share capital 2,247,731 -
Share issue costs (77,788) -
---------------------------------------------------------- ------------ ----------
Net cash generated from investing activities 1,569,943 -
---------------------------------------------------------- ------------ ----------
Increase/(decrease) in cash and cash equivalents 659,014 (27,868)
Cash and cash equivalents at the beginning of the period 578,702 606,570
---------------------------------------------------------- ------------ ----------
Cash and cash equivalents at the end of the period 1,237,716 578,702
---------------------------------------------------------- ------------ ----------
Consolidated and Company Statements of Changes in Equity
For the year ended 31 March 2017
Group Share Share premium Shares to be Warrant Capital Retained Total
capital issued reserve redemption earnings
reserve
GBP GBP GBP GBP GBP GBP GBP
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
As at 31 March 2015 553,213 3,067,097 1,000,000 62,000 - (3,253,818) 1,428,492
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
Shares issued in
year 14,817 1,198,249 (1,000,000) - - - 213,066
Share
reclassification* 98 (98) - - - - -
Warrants expired
in year - - - (62,000) - 62,000 -
Total comprehensive
loss for the year - - - - - (582,861) (582,861)
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
As at 31 March 2016 568,128 4,265,248 - - - (3,774,679) 1,058,697
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
Shares issued in
year 25,025 2,674,918 - - - - 2,699,943
Warrants expired - - - - - - -
in year
Purchase and
cancellation of
Deferred shares (550,701) - - - 550,701 - -
Capital reduction - (6,940,166) - - (550,701) 7,490,867 -
Total comprehensive
loss for the year - - - - - (2,009,793) (2,009,793)
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
As at 31 March 2017 42,452 - - - - 1,706,395 1,748,847
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
Company Share Share premium Shares to be Warrant Capital Retained Total
capital issued reserve redemption earnings
reserve
GBP GBP GBP GBP GBP GBP GBP
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
As at 31 March 2015 553,213 3,067,097 1,000,000 62,000 - (3,246,621) 1,435,689
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
Shares issued in
year 14,817 1,198,249 (1,000,000) - - - 213,066
Share
reclassification* 98 (98) - - - - -
Warrants expired
in year - - - (62,000) - 62,000 -
Total comprehensive
loss for the year - - - - - (582,220) (582,220)
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
As at 31 March 2016 568,128 4,265,248 - - - (3,766,841) 1,066,535
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
Shares issued in
year 25,025 2,674,918 - - - - 2,699,943
Warrants expired - - - - - - -
in year
Purchase and
cancellation of
Deferred shares (550,701) - - - 550,701 - -
Capital reduction - (6,940,166) - - (550,701) 7,490,867 -
Total comprehensive
loss for the year - - - - - (2,017,631) (2,017,631)
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
As at 31 March 2017 42,452 - - - - 1,706,395 1,748,847
-------------------- ----------- ------------- ------------ ------------- ------------ ------------ -----------
* The share reclassification in the year ended 31 March 2016 was
to correct the allocation between share capital and share premium
for shares issued in prior years. This had no effect on the number
of shares in issue.
1. BASIS OF PRESENTATION
Basis of presentation and statement of compliance
The financial statements have been prepared in accordance with
International Financial Reporting Standards ("IFRS") as issued by
the International Accounting Standards Board ("IASB") and as
adopted by the European Union.
Basis of consolidation
The Group financial statements include the financial statements
of the Company and its dormant subsidiary undertaking Mercom Oil
Sands Canada Inc., a company incorporated in Canada. The results of
subsidiary undertakings sold or acquired are included in the
Consolidated Statement of Comprehensive Income up to, or from the
date control passes. Intra group sales and profits are eliminated
fully on consolidation.
Functional currency
The presentational and functional currency of the Group and
Company is U.K Pounds Sterling.
Significant accounting estimates and judgments
The preparation of these financial statements requires
management to make judgements and estimates that affect the
reported amounts of assets and liabilities at the date of the
financial statements and reported amounts of expenses during the
reporting period. Actual outcomes could differ from these judgments
and estimates. The financial statements include judgments and
estimates which, by their nature, are uncertain. The impacts of
such judgments and estimates are pervasive throughout the financial
statements, and may require accounting adjustments based on future
occurrences. Revisions to accounting estimates are recognised in
the period in which the estimate is revised and the revision
affects both current and future periods.
Significant assumptions about the future and other sources of
judgments and estimates that management has made at the statement
of financial position date, that could result in a material
adjustment to the carrying amounts of assets and liabilities, in
the event that actual results differ from assumptions made, relate
to, but are not limited to, the following:
-- The accounting treatment of the available for sale financial assets;
-- The valuation of available for sale financial assets; and
-- The judgment that significant influence is not exercised by
the Group over any of the investments as detailed in note 8.
Going concern
These financial statements have been prepared in accordance with
International Financial Reporting Standards ("IFRS") applicable to
a going concern, which assume that the Group will be able to
realise its assets and discharge its liabilities in the normal
course of operations. The Group has no current source of operating
revenues and its capacity to operate as a going concern in the
near-term will likely depend on its ability to continue raising
equity or debt financing. There can be no assurance that the Group
will be able to continue to raise funds in which case the Group may
be unable to meet its obligations. Should the Group be unable to
realise on its assets and discharge its liabilities in the normal
course of business, the net realisable value of its assets may be
materially less than the amounts recorded in the Consolidated and
Company Statements of Financial Position.
The Directors consider that given the level of expenses the
Group expects to incur and the significant cash reserves held by
the Group will be sufficient to continue in operation and meet its
liabilities as they fall due for a period of no less than twelve
months from the date of approval of these financial statements.
The financial statements do not include adjustments to amounts
and classifications of assets and liabilities that might be
necessary should the Group be unable to continue in operation.
2. SIGNIFICANT ACCOUNTING POLICIES
Investments
Investments in subsidiaries, associates and joint ventures, and
other investments are presented in the Parent Company financial
statements at cost, less any necessary provision for
impairment.
Associates
Associates are entities over which the Group exercises
significant influence but does not exercise control. Investments in
associates are accounted for using the equity method of accounting
and are initially recognised at cost, which includes goodwill
identified on acquisition, net of any accumulated impairment loss.
The Group's share of its associate's profits or losses after
acquisition of its interest is recognised in profit or loss and
cumulative post-acquisition movements are adjusted against the
carrying amount of the investment. Where the Group's share of
losses of an associate equals or exceeds the carrying amount of the
investment, the Group only recognises further losses where it has
incurred obligations or made payments on behalf of the
associate.
Entities where the Group has a holding of 20% or more but does
not exercise significant influence are accounted for as available
for sale financial assets. Significant influence is not therefore
considered to be exercised in respect of the available for sale
financial assets detailed in note 8 as in all cases the Company has
no right to appoint directors and has no ability to influence the
strategic and operational decisions taken.
Financial assets
Available for sale financial assets consist of equity
investments in other companies or limited partnerships where the
Group does not exercise either control or significant
influence.
Available for sale financial assets are shown at fair value at
each reporting date with changes in fair value being shown in Other
Comprehensive Income, or at cost less any necessary provision for
impairment where a reliable estimate of fair value is not able to
be determined.
All assets for which fair value is measured or disclosed in the
financial statements are categorised within the fair value
hierarchy, described as follows, based on the lowest level input
that is significant to the fair value measurement as a whole:
-- Level 1 - Quoted (unadjusted) market prices in active markets
for identical assets or liabilities.
-- Level 2 - Valuation techniques for which the lowest level
input that is significant to the fair value measurement is directly
or indirectly observable.
-- Level 3 - Valuation techniques for which the lowest level
input that is significant to the fair value measurement is
unobservable.
The valuation technique applied to the available for sale
financial assets in the current period is a Level 3 technique.
Corporation tax
Corporation tax on the profit or loss for the period presented
comprises current and deferred tax. Corporation tax is recognised
in profit or loss except to the extent that it relates to items
recognised directly in equity, in which case it is recognised in
equity.
Current tax expense is the expected tax payable on the taxable
income for the period, using tax rates enacted or substantively
enacted at the period end.
2. SIGNIFICANT ACCOUNTING POLICIES (continued)
Deferred tax is recorded using the asset and liability method,
providing for temporary differences, between the carrying amounts
of assets and liabilities for financial reporting purposes and the
amounts used for taxation purposes. The following temporary
differences are not provided for: goodwill not-deductible for tax
purposes; the initial recognition of assets or liabilities that
affect neither accounting or taxable loss; and differences relating
to investments in subsidiaries to the extent that they will
probably not reverse in the foreseeable future. The amount of
deferred tax provided is based on the expected manner of
realisation or settlement of the carrying amount of assets and
liabilities, using tax rates enacted or substantively enacted at
the period end date.
A deferred tax asset is recognised only to the extent that it is
probable that future taxable profits will be available against
which the asset can be utilised. To the extent that the Group does
not consider it probable that a future tax asset will be recovered,
the tax asset is not recognised.
Deferred tax assets and liabilities are offset when there is a
legally enforceable right to set off current tax assets against
current tax liabilities and when they relate to income taxes levied
by the same taxation authority and the Group intends to settle its
current tax assets and liabilities on a net basis.
Cash and cash equivalents
Cash and cash equivalents consist of cash on deposit with banks
and short-term interest-bearing investments with maturities of 90
days or less from the original date of acquisition. Cash and cash
equivalents are recorded at fair value and changes in fair value
would be reflected in profit or loss in the Consolidated Statement
of Comprehensive Income. Cash and cash equivalents at the year end
include GBP1,199,679 (2016:GBPnil) which are held by the Company's
legal and PR communications advisors.
Warrants
Warrants issued are accounted for using the fair value method
and result in share issue costs and a credit to the warrants
reserve when the warrants are issued. When warrants are exercised,
the corresponding warrant fair value and the proceeds received by
the Group are credited to share capital. When warrants expire, the
corresponding fair value is credited to the accumulated
deficit.
Loss per share
Basic loss per share is calculated using the weighted average
number of shares outstanding. Diluted loss per share assumes that
any proceeds from the exercise of dilutive stock options and
warrants would be used to repurchase Ordinary shares at the average
market price during the period, with the incremental number of
shares being included in the denominator of the diluted earnings
per share calculation.
During the year ended 31 March 2017, all issued and outstanding
warrants and options were anti-dilutive and were excluded from the
diluted loss per share calculations.
Foreign currency translation
The functional and presentational currency of the Group is U.K
Pounds Sterling. Transactions in currencies other than the
functional currency are recorded at the rates of exchange
prevailing on dates of transactions. At each period end date
monetary assets and liabilities denominated in foreign currencies
at the reporting date are translated to U.K Pounds Sterling at the
exchange rate at that date. Foreign exchange differences arising on
translation are recognised in profit or loss in the Consolidated
Statement of Comprehensive Income. Non-monetary assets and
liabilities that are measured at historical cost are translated
using the exchange rate at the date of the transaction.
2. SIGNIFICANT ACCOUNTING POLICIES (continued)
Impairment of assets
At each period end date, assets are reviewed for impairment if
there is any indication that the carrying amount may not be
recoverable. If any such indication is present, the recoverable
amount of the asset is estimated in order to determine whether
impairment exists. Where the asset does not generate cash flows
that are independent from other assets, the Group estimates the
recoverable amount of the cash-generating unit (CGU) to which the
asset belongs. Any intangible asset with an indefinite useful life
is tested for impairment annually and whenever there is an
indication that the asset may be impaired.
An asset's recoverable amount is the higher of fair value less
costs to sell and value in use. In assessing value in use, the
estimated future cash flows are discounted to their present value,
using a pre-tax discount rate that reflects current market
assessments of the time value of money and the risks specific to
the asset for which estimates of future cash flows have not been
adjusted.
If the recoverable amount of an asset or CGU is estimated to be
less than its carrying amount, the carrying amount is reduced to
the recoverable amount. Impairment is recognised immediately as
additional depreciation. Where an impairment subsequently reverses,
the carrying amount is increased to the revised estimate of
recoverable amount but only to the extent that this does not exceed
the carrying value that would have been determined if no impairment
had previously been recognised. A reversal is recognised as a
reduction in the depreciation charge for the period.
Share issue costs
Costs incurred for the issue of Ordinary shares are deducted
from the share premium arising on that issue.
Revenue recognition
The Group did not generate revenue in the current or previous
year.
Financial Instruments
Financial assets
The Group classifies its financial assets into one of the
following categories, depending on the purpose for which the asset
was acquired. The Group's accounting policy for each category is as
follows:
Fair value through profit or loss - This category comprises
derivatives, or assets acquired or incurred principally for the
purpose of selling or repurchasing it in the near term. They are
carried in the Consolidated and Company Statements of Financial
Position at fair value with changes in fair value recognised in the
Consolidated Statement of Comprehensive Income.
Loans and receivables - These assets are non-derivative
financial assets with fixed or determinable payments that are not
quoted in an active market. They are carried at cost less any
provision for impairment. Individually significant receivables are
considered for impairment when they are past due or when other
objective evidence is received that a specific counterparty will
default.
Held-to-maturity investments - These assets are non-derivative
financial assets with fixed or determinable payments and fixed
maturities that the Group's management has the positive intention
and ability to hold to maturity. These assets are measured at
amortised cost using the effective interest method. If there is
objective evidence that the investment is impaired, determined by
reference to external credit ratings and other relevant indicators,
the financial asset is measured at the present value of estimated
future cash flows. Any changes to the carrying amount of the
investment, including impairment losses, are recognised in profit
or loss.
2. SIGNIFICANT ACCOUNTING POLICIES (continued)
Available-for-sale - Non-derivative financial assets not
included in the above categories are classified as
available-for-sale. They are carried at fair value with changes in
fair value recognised in Other Comprehensive Income. Where a
decline in the fair value of an available-for-sale financial asset
constitutes objective evidence of impairment, the amount of the
loss is removed from Other Comprehensive Income and recognised in
profit or loss.
All financial assets except for those at fair value through
profit or loss are subject to review for impairment at least at
each reporting date. Financial assets are impaired when there is
any objective evidence that a financial asset or a group of
financial assets is impaired. Different criteria to determine
impairment are applied for each category of financial assets, which
are described above.
Financial liabilities
The Group classifies its financial liabilities into one of two
categories, depending on the purpose for which the asset was
acquired. The Group's accounting policy for each category is as
follows:
Fair value through profit or loss - This category comprises
derivatives, or liabilities acquired or incurred principally for
the purpose of selling or repurchasing it in the near term. They
are carried in the Consolidated and Company Statements of Financial
Position at fair value with changes in fair value recognised in
profit or loss.
Other financial liabilities - This category includes promissory
notes, amounts due to related parties and accounts payables and
accrued liabilities, all of which are recognised at amortised
cost.
The Group's financial instruments consist of the following:
Financial assets: Classification:
Cash and cash equivalents Loans and receivables
Other receivables Loans and receivables
Financial liabilities: Classification:
Accounts payable and accrued liabilities Other financial
liabilities
During the year ended 31 March 2017 the Group adopted a number
of new IFRS standards, interpretations, amendments and improvements
to existing standards. These new standards and changes did not have
any material impact on the Company's financial statements.
The following IFRS and IFRIC Interpretations have been issued
but have not been applied by the Group in preparing these financial
statements as they are not as yet effective and in some cases had
not yet been adopted by the EU. The Company intends to adopt these
Standards and Interpretations when they become effective, rather
than adopt them early.
-- IFRS 9, 'Financial Instruments'
-- IFRS 15, 'Revenue from Contracts with Customers'
-- IFRS 16 'Leases'
-- IFRS 10 and IAS 28 (amendments), 'Sale or Contribution of
Assets between an Investor and its Associate or Joint Venture'
-- Amendments to IFRS 2, 'Classification and Measurement of
Share-based Payment Transactions'
-- Amendments to IAS 7, 'Disclosure Initiative'
-- Amendments to IAS 12, 'Recognition of Deferred Tax Assets for Unrealised Losses'
The directors do not expect that the adoption of the Standards
listed above will have a material impact on the Group in future
periods except that IFRS 9 will impact both the measurement and
disclosure of financial instruments and IFRS 15 may have an impact
on revenue recognition and related disclosures when the Group
becomes revenue generative. Beyond this, it is not practicable
2. SIGNIFICANT ACCOUNTING POLICIES (continued)
to provide a reasonable estimate of the effect of IFRS 9 and
IFRS 15 until a detailed review has been completed.
IFRS 16 is a significant change to leasee accounting and all
leases will require balance sheet recognition of a liability and a
right-of-use asset except short term leases and leases of low value
assets. The effect on the Group in the future cannot be accurately
quantified at this stage.
A number of IFRS and IFRIC interpretations are also currently in
issue which are not relevant for the Group's activities and which
have not therefore been adopted in preparing these financial
statements.
3. CAPITAL AND FINANCIAL RISK MANAGEMENT
The capital of the Group consists of shareholders' equity. The
Group's objectives when managing capital are to safeguard the
Group's ability to continue as a going concern in order to pursue
the development of its financial assets and to maintain optimal
returns to shareholders and benefits for other stakeholders.
The Group manages its capital structure and makes adjustments to
it in light of changes in economic conditions and the risk
characteristics of the underlying assets. To maintain or adjust its
capital structure, the Group may attempt to issue new shares or
debt, dispose of assets, or adjust the amount of cash and cash
equivalents.
Management reviews its capital management approach on an ongoing
basis and believes that this approach, given the relative size of
the Group, is reasonable. There were no changes in the Group's
approach to capital management during the year ended 31 March 2017.
The Group is not subject to externally imposed capital
requirements.
Credit risk
All the Group's cash and cash equivalents are held with
well-known and established financial institutions except as
detailed in note 2. As such, management considers credit risk
related to these financial assets to be minimal. The Group's
maximum credit risk exposure is limited to the carrying value of
its cash and subscriptions receivable. At 31 March 2017 the Group
had no material amounts deemed to be uncollectible.
Commodity price risk
The Group is currently in its development stage and as such the
exposure to fluctuations in commodity prices is not actively
managed.
Interest rate risk
Interest rate risk is the risk that future cash flows will
fluctuate as a result of changes in market interest rates. The
Group does not have a material exposure to this risk as there are
no outstanding debt facilities.
Liquidity risk
Liquidity risk is the risk that the Group will not be able to
meet its financial obligations as they become due. The Group
ensures, as far as possible, that it will have sufficient liquidity
to meet its liabilities when due, without incurring unacceptable
losses or harm to the Group's reputation.
The Group utilises authorisation for expenditures to further
manage capital expenditures and attempts to match its payment cycle
with available cash resources.
3. CAPITAL AND FINANCIAL RISK MANAGEMENT
Foreign currency risk
The Group is exposed to foreign currency fluctuations on its
cash and cash equivalents which is denominated in U.K. Pounds
Sterling and Canadian dollars.
4. LOSS FOR THE YEAR BEFORE TAXATION
2017 2016
GBP GBP
Loss for the year before
taxation is stated after
charging/ (crediting):
Shares issued for services
and settlement of debt 530,000 213,066
Foreign exchange
loss/(gain) 28,052 (284)
------------------------------------- -------- --------
Fees payable to the Company's
auditors for:
- the audit of the Company's
annual accounts 28,575 18,615
Total audit
fees 28,575 18,615
------------------------------------- -------- --------
Fees payable to the Company's
auditors for:
- taxation compliance
services 1,425 1,385
- other services - -
-------------------------------- -------- --------
Total other
fees 1,425 1,385
------------------------------------- -------- --------
5. EXCEPTIONAL ITEMS
2017 2016
GBP GBP
Professional costs re: Calvet
proposal, change of Board 1,140,243
and Investment policy -
Termination costs of previous
Board, previous Nomad and 55,476
two previous joint brokers -
Impairment of available
for sale financial assets 300,000 268,632
---------------------------------- ------------ --------
1,495,719 268,632
------------------------------- ------------ --------
The year ended 31 March 2017 has been one of transformational
change resulting in a complete change of management, advisers and
future direction for the Company. This has involved significant
one-off costs which are itemised in this note. On 21 October 2016
the Company announced that it was in discussions with Calvet, an
activist shareholder, regarding a proposal to replace the Board. On
23 December 2016 the then Directors resigned and the current Board
was appointed.
The professional costs associated with the initial approach from
Calvet, the subsequent submission to the Panel on Takeovers and
Mergers and the fees of both the exiting and incoming nominated
advisors, legal advisors and other professional advisors amounted
to GBP1,140,243, of which GBP530,000 was settled by the issue of
shares at 40p per share, as detailed in note 4.
Additionally, the termination costs in January 2017 of the
Company's previous Nominated Advisor and its previous two joint
brokers amounted to GBP59,587 and the termination costs of the
previous Board amounted to GBP138,000 less the contributions
payable under their Settlement Agreements of GBP142,111 as detailed
in note 6.
5. EXCEPTIONAL ITEMS (continued)
On 28 May 2014, the Company made a GBP300,000 investment in Viet
Energy Ltd and on 17 October 2016 the Company made a GBP600,000
investment in a Mexican fintech company MOWISAT Mexico SAPI. The
Company is in advanced discussions to dispose of the investments in
Viet Energy Ltd and MOWISAT Mexico SAPI for a total cash
consideration of GBP600,000. As a result of these ongoing
discussions (and no other parties being interested in the
acquisition of these investments) the Directors have concluded that
the carrying value should be impaired by GBP300,000. The Directors
consider that it is not possible to specifically allocate the
GBP300,000 impairment against either of the two investments.
The exceptional item in the prior year relates to an impairment
of the Group's investments in Lion Natural Resources Limited of
GBP200,000 and Maverick Petroleum Ltd of GBP68,632.
The impairment of the investment in Lion Natural Resources
Limited was a result of (i) Askia Gold Limited being dissolved and
(ii) the uncertainty of the ability of Advance Gold Corp. to
continue in business, both being underlying investments of Lion
Natural Resources Limited. The impairment of Maverick Petroleum Ltd
was due to the return of the option to acquire the Sadiq Oil
Concession by the company, its only asset. There has been no change
in the status of these companies in the year ended 31 March
2017.
6. EMPLOYEES
2017 2016
Number Number
The average weekly number of employees
(including Directors) during the
year was:
Management 3 3
--------------------------------------------------- -------- --------
There were no staff costs in the year except for
those described below in respect of the Directors.
Key management personnel are those persons having
the authority and responsibility for planning,
controlling and directing the activities of the
Group. In the opinion of the Board, the Group's
key management personnel are the Directors of
the Company and information regarding their remuneration
is provided below.
Remuneration in respect of the
Directors was as follows: 2017 2016
GBP GBP
Aggregate emoluments (including
benefits in kind) - -
Fees 190,889 180,000
--------------------------------------------- --- -------- --------
190,889 180,000
--- -------- --------
Remuneration for each Director
(including benefits in kind) 2017 2016
GBP GBP
K Appleby 30,000 36,000
Dr PH Cross 5,861 24,000
J Zorbas 98,028 120,000
S Fry 6,000 -
JP Tranie 36,000 -
FW Simonsen 15,000 -
190,889 180,000
---------------------------------------- ---------- ---------
The remuneration for K Appleby, Dr PH Cross and
J Zorbas includes compensation for loss of office
of GBP12,000, GBP6,000 and GBP120,000 respectively.
The remuneration for Dr PH Cross and J Zorbas
is net of contributions to the
6. EMPLOYEES (continued)
company payable under their Settlement Agreements
of GBP18,139 and GBP123,972 respectively. These
have been credited in the remuneration detailed
above.
The remuneration for J Zorbas includes GBP12,000
rental accommodation costs invoiced to the Company
in the year.
On 23 December 2016 Dr PH Cross, K Appleby and
J Zorbas resigned.
On 23 December 2016 S Fry, JP Tranie and FW Simonsen
entered into Letters of Appointment to act as
Directors with each Director receiving a fixed
first year remuneration of GBP24,000 that on a
quarterly basis in arrears is converted into a
fixed 15,000 ordinary shares of the Company at
40p per share. At 31 March 2017 the shares had
not yet been issued.
In addition to their fixed first quarter remuneration
as detailed above JP Tranie and FW Simonsen invoiced
the company GBP30,000 and GBP9,000 respectively
for additional services rendered in the period
relating to work done prior to their Board appointments.
7. TAXATION
Taxation 2017 2016
GBP GBP
(a) Analysis
of charge in
year
Current tax:
Corporation tax - -
----------------------------------- ------------ ----------
Total current
tax - -
------------------------------ --- ------------ ----------
(b) Factors affecting the tax
charge for the year
The tax assessed for the year is lower than
the standard rate of corporation tax in the
UK of 20% (2016: 20%).
The differences are
explained below:
2017 2016
GBP GBP
Loss on ordinary activities
before tax (2,009,793) (582,861)
----------------------------------- ------------ ----------
Loss on ordinary activities multiplied by the
standard rate of corporation tax of
20% (2016:20%) (401,959) (116,572)
Effects of:
Expenses not deductible
for tax purposes 60,000 53,854
Loss carried
forward 341,959 62,718
Current tax charge
for the year - -
----------------------------------- ------------ ----------
(c) Factors that may affect future tax charges
No deferred tax asset has been recognised on
losses carried forward in the Company due to
the uncertainty of the timing of taxable profits.
8. INVESTMENTS
Group and Company
a) Available for sale financial assets
Cost GBP
At 1 April 2016 768,632
Additions 600,000
31 March 2017 1,368,632
---------------------- ---------
Impairment
At 1 April 2016 468,632
Impairment in year 300,000
---------------------- ---------
At 31 March 2017 768,632
---------------------- ---------
Net book value
31 March 2017 600,000
---------------------- ---------
31 March 2016 300,000
---------------------- ---------
The cost represents investments in the following companies:
County Holding Proportion Nature of business
of Incorporation held
Lion Natural England Ordinary 30% Direct exploration
Resources & Wales and development
Limited of natural resources
Viet Energy Cyprus Ordinary 35% Direct exploration
Ltd (ex NWT and development
Coal Limited) of natural resources
Maverick Petroleum Republic Ordinary 2% Direct and indirect
Ltd of Seychelles exploration and
development of
natural resources
MOWISAT Mexico Mexico Ordinary 16% Telecommunications
SAPI
The impairment in the year is in respect of MOWISAT Mexico SAPI
and Viet Energy Ltd and in the prior year in respect of Lion
Natural Resources Limited and Maverick Petroleum Ltd, as detailed
in note 5.
The accounting treatment of the investments in Lion Natural
Resources Limited and Viet Energy Ltd as available for sale
financial assets and not as associates is detailed in note 2. These
investments are measured at cost less impairment as also detailed
in note 2 as it is not possible to reliably measure a fair
value.
The Company is in advanced discussions to dispose of the
investments in Viet Energy Ltd and MOWISAT Mexico SAPI for a total
cash consideration of GBP600,000. As a result of these ongoing
discussions (and no other parties being interested in the
acquisition of these investments) the Directors have concluded that
the carrying value should be impaired by GBP300,000. The Directors
consider that it is not possible to specifically allocate the
GBP300,000 impairment against either of the two investments.
8. INVESTMENTS (continued)
b) Investment in subsidiary
undertaking
The Company has a shareholding in the following
dormant company incorporated in Canada:
Subsidiary undertakings Holding Proportion
held Nature
of Business
Mercom Oil Sands Canada Common shares 100% Investment
Inc. (Nil Par company
Value)
This company is in the process of being dissolved and has been
fully impaired at 31 March 2017 and 2016.
9. TRADE AND OTHER RECEIVABLES
Group Group Company Company
2017 2016 2017 2016
GBP GBP GBP GBP
Amounts owed by group
undertakings - - - 453,943
Other receivables 49,339 432,109 49,339 -
------- -------- -------- --------
49,339 432,109 49,339 453,943
======= ======== ======== ========
On 10 January 2013, the Group entered in to a
contract to purchase 20,000 cubic meters of Gasoil
at a price of US$775 per cubic meter. On entering
the contract the Group paid a refundable deposit
of GBP499,900. If the Group chose not to perform
on the contract, the deposit would be refunded.
The contractor, at their sole discretion, had
the right to impose a 2.25% fee for any amounts
refunded for non-performance. The contract was
extended to 1 July 2016 and the deposit was refunded
in full in August 2016 less the non-performance
fee.
10. TRADE AND OTHER PAYABLES
Group Group Company Company
2017 2016 2017 2016
GBP GBP GBP GBP
Trade payables 36,280 124,110 36,280 124,110
Accruals and deferred
income 101,928 142,000 101,928 142,000
-------- -------- -------- --------
138,208 266,110 138,208 266,110
======== ======== ======== ========
11. RELATED PARTY TRANSACTIONS AND BALANCES
The Group's and Company's related parties, as
defined by International Accounting Standard
24 (revised), the nature of the relationship
and the amount of transactions with them during
the year ended 31 March 2017 were as follows:
During the year Captor Capital Corp, formerly NWT Uranium Corp.,
company in which J Zorbas, a director of the Company in the year,
has an interest, charged the Group GBP28,860 for office space and
staff expenses.
12. SHARE CAPITAL
a) Shares authorised
On 16 July 2014 the Company consolidated its
share capital so that every 50 Ordinary shares
of GBP0.001 in the issued share capital of
the Company was consolidated into one Ordinary
share of GBP0.05 (New Ordinary share). Each
New Ordinary share would have the same rights
and would be subject to the same restrictions
as an Ordinary share. Following the consolidation
the New Ordinary shares were sub divided into
one Ordinary share of GBP0.001 and one Deferred
share of GBP0.049.
b) Ordinary shares issued
Called up, allotted and fully paid:
2017 2016
GBP GBP
42,452,063 (2016 - 17,426,773)
Ordinary shares of GBP0.001 42,452 17,427
Nil (2016- 11,238,797) Deferred
shares of GBP0.049 - 550,701
--------------------------------------- -------- --------
42,452 568,128
--------------------------------------- -------- --------
On 24 January 2017 the Company purchased and
cancelled the 11,238,797 Deferred shares.
On 1 March 2017 the Company cancelled the capital
redemption reserve and share premium account
by Special Resolution, as confirmed by an Order
of the High Court of Justice, Chancery Division.
The Company issued shares in the year as follows:
(i) On 20 July 2016 the Company issued 12,100,000
Ordinary Shares at a price of 2.5p per Placing
Share raising GBP302,500 before expenses. This
also included the issuance of associated Warrants
over Ordinary Shares on the basis of one warrant
for every two Placing Shares exercisable at
price of 5p per share.
(ii) On 27 October 2016 2,850,000 Warrants
were exercised raising GBP142,500
(iii) On 4 November 2016 200,000 Warrants were
exercised at 5p raising GBP10,000
(iv) On 30 November 2016 250,000 Warrants were
exercised raising GBP12,500
(v) On 8 December 2016 500,000 Warrants were
exercised raising GBP25,000
(vi) On 13 December 2016 1,500,000 Warrants
were exercised raising GBP75,000
(vii) On 21 December 2016 1,750,000 Warrants
were exercised raising GBP87,500
(viii) On 10 February 2017 6,000,000 shares
were placed at 35p raising GBP2,100,000(*)
(ix) On 20 March 2017 289 shares were issued
following the exercise of Bonus Warrants at
80p
(x) On 29 March one share was issued following
the exercise of Bonus Warrants at 80p
(xi) During the financial period the Company
issued a total of 1,325,000 shares at 40p for
the settlement of professional expenses and
investment due diligence cost of GBP530,000
(*) 1,450,000 of these shares were issued after the year end and
are therefore not included in the total issued number of shares at
the year end.
c) Share options
On 31 December 2016 the Board adopted the Directors and Senior
Management Option Scheme. The initial exercise price under the
Scheme was set at 35p per share, representing a premium of 19.7% to
the closing mid market price of 29.25p per share on 30 December
2016. There was a subsequent grant made on 29 March 2017 with an
exercise price under the Scheme at 80p per share, representing a
premium of 139% to the closing mid market price of 33.5p per share
on 28 March 2017.
12. SHARE CAPITAL (continued)
Number of options
granted
31 Dec 29 March
2016 2017
Non- executive
JP Tranié Director 2,000,000 1,000,000
F Simonsen Finance Director 2,000,000 -
S Fry Chairman - 2,000,000
The options granted on 31 December 2016 and 29 March 2017 are
exercisable at 35p per share and 80p per share respectively. All
options vest over a three year period with 40% at the end of the
first year, a further 30% at the end of the second year and the
final 30% at the end of the third year. The blended average price
per outstanding option is 55.3p per share.
The maximum number of options that can be granted under this
scheme is set at 10 million.
It is the stated objective of the new Board that their interests
will be strongly aligned with shareholders, being well rewarded
only in the event of significant shareholder value creation in the
medium to long term.
13. LOSS PER ORDINARY SHARE
Basic loss per share is calculated by dividing the loss
attributable to equity holders of the Company by the weighted
average number of Ordinary shares in issue during the year.
2017 2016
Loss attributable to equity holders of the Company GBP (2,009,793) GBP (582,861)
Weighted average number of Ordinary shares in issue 30,412,214 16,208,363
----------------------------------------------------- ---------------- --------------
Basic loss per share (6.6p) (3.6p)
----------------------------------------------------- ---------------- --------------
Diluted loss per share is calculated by adjusting the weighted
average number of Ordinary shares in issue to assume the conversion
of all dilutive potential ordinary shares at the start of the
period. The Company's dilutive potential Ordinary shares arise from
warrants. In respect of the warrants a calculation is performed to
determine the number of shares that could have been acquired at
fair value, based upon the monetary value of the subscription
rights attached to the outstanding warrants. The number of shares
calculated as above is compared with the number of shares that
would have been issued assuming the exercise of the warrants.
2017 2016
Loss attributable to equity holders of the Company GBP(2,017,631) GBP(582,220)
Weighted average number of Ordinary shares in issue 30,412,214 16,208,363
Dilutive warrants - -
----------------------------------------------------------------------------------- --------------- ----------------
Weighted average number of Ordinary shares used to determine diluted loss per
share 30,412,214 16,208,363
Diluted loss per share (6.6p) (3.6p)
----------------------------------------------------------------------------------- --------------- ----------------
Headline loss per ordinary share is also shown. This excludes
exceptional items of GBP1,495,719 (2016: GBP268,632) and shows the
loss per ordinary share on an underlying basis at (1.7p) (2016:
(1.9p)).
14. ULTIMATE CONTROLLING PARTY
In the opinion of the Directors there is no ultimate controlling
party.
15. SUBSEQUENT EVENTS
Post year end the Company announced that it is in an advance
stage to complete its first major conviction investment. It
furthermore announced its intentions to seek Admission of the
Official List (by way of Standard Listing under Chapter 14 of the
Listing Rules) and to trading on the London Stock Exchange's main
market for listed securities.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FR LLFEFATIIFID
(END) Dow Jones Newswires
September 20, 2017 09:05 ET (13:05 GMT)
Monchhichi (LSE:MCC)
Historical Stock Chart
From May 2024 to Jun 2024
Monchhichi (LSE:MCC)
Historical Stock Chart
From Jun 2023 to Jun 2024